Nephrology Training Program Director, #HenryFordHospital @HFHNephFellow. Professor of Clinical Medicine, @MSUMD.
Detroit, MI
Joined December 2017
- Tweets1.6K
- Following438
- Followers1.9K
- Likes1.1K
James Novak, MD PhD FACP FASN FNKF retweeted
Congratulations to incoming @HFHNephFellow fellows Abdelhadi Farouji, Aqsa Pervez, and Ali Taleb and nephrology/critical care fellow Srinidhi Shyamkumar! @HFHIntMedRes @HenryFordHealth
Congratulations to our 2024 @HFHNephFellow graduates, Drs. @klodiahermez and @AmulyaRajagopal (who sent me a lovely parting gift shown below)!
James Novak, MD PhD FACP FASN FNKF retweeted
Our first-year #nephrology fellow Sandeep Kaur presenting at @nkf Spring Clinical Meeting! @HenryFordHealth @HFHIntMedRes
My son Josh was admitted to and has enrolled at #Purdue @LifeAtPurdue for Fall 2024. We’re super excited to be a #Boilermaker family! #OnlyPurdue
IntraCity Kidney Grand Rounds with @HFHNephFellow fellows, left to right, Hazem Albashash, Stefani Thompson, Luis Osorio, and Amulya Rajagopal.
A photogenic and talented group of physicians!
A great evening! @HFHNephFellow at the IntraCity Kidney Grand Rounds hosted by Beaumont Farmington Hills.
#nephrotwitter #renalgrandrounds #detroit
James Novak, MD PhD FACP FASN FNKF retweeted
We're pleased to announce that we filled all positions in the #NRMP #Match2024. Introducing next year's fellows: Ryan Goleniak and Muhammad Monk, MDs (nephrology/critical care) and Tseng “Alex” Huang and Jocelynn Rajanayagam (nephrology). Congratulations to all!
Encouraging findings about GLP1 (below), also GIP and glucagon triple therapy (not shown): #KidneyWk
Dr. Mark Perazella honoring the late Dr. Jerry Yee and his wife Virginia at the @ASNKidney President’s Dinner. @HFHNephFellow
James Novak, MD PhD FACP FASN FNKF retweeted
One step closer to forgetting bardoxolone exists.
Still quite like our 2nd sentence in the NephJC CARDINAL discussion.
nephjc.com/news/bardoxolone
James Novak, MD PhD FACP FASN FNKF retweeted
@HFHNephFellow at @ASNKidney #KidneyWeek, left to right: Ryann Sohaney, @meaghan1021, @klodiahermez, Amulya Rajagopal, and @JamesNovakNeph. @HenryFordHealth
No benefit to anticoagulation with warfarin (limited data with DOACs) to prevent vascular access loss: @ASNKidney #KidneyWeek
But improved composite kidney endpoint with sparsentan:
Sparsentan also better than irbesartan for proteinuria, and maybe slightly for eGFR decline, in IgAN: @ASNKidney #KidneyWeek
Sparsentan also better than irbesartan for proteinuria, and maybe slightly for eGFR decline, in IgAN: @ASNKidney #KidneyWeek
Just in: sparsentan better than irbesartan for proteinuria reduction, although not eGFR change, in primary FSGS: @ASNKidney #KidneyWeek
Update in glomerular disease: no #SGLT2 unless hyperfiltration (DKD, CHF, obesity); no benefit in EMPA-KIDNEY with normal UAE: @ASNKidney #KidneyWeek
